Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
Therapeutic intervention of LRRK2 kinase inhibitors in Vps35 p.D620N Parkinsonism
Physiology and Pathophysiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
Three-dimensional gait analysis of the effect of directional steering in Parkinson’s disease
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Tissue Engineered Nigrostriatal Pathway as an Anatomically-Inspired Test-Bed for Evaluating Axonal Pathophysiology
Physiology and Pathophysiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Tractography-based targeting of the ventral intermediate nucleus for asleep DBS implantation
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Transcranial MR guided FUS thalamotomy in essential tremor: a comprehensive lesion characterization
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Transcranial Photobiomodulation as an adjunct to Levodopa therapy in patients with Parkinson’s Disease; an open label pilot study
Non-Pharmacological Interventions · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson’s disease mouse model
Non-Pharmacological Interventions · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Transient orthostatic blood pressure changes in Parkinson’s Disease: impact on falls, syncope and orthostatic intolerance
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Translation of a subject-specific stereotaxic platform to a large animal deep brain stimulation research models
Physiology and Pathophysiology · Les Muses, Level 3
- «Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 67
- Next Page»